David Dodd | Chairman and Chief Executive Officer |
Mark Reynolds | Chief Financial Officer |
Mark Newman | Chief Scientific Officer |
John Sharkey | Head, Business Development |
Jason McCarthy | Maxim Group |
Jeff Kraws | Crystal Research |
Kumarguru Raja | Brookline Capital Markets |
Good afternoon and welcome everyone to the GeoVax Second Quarter 2022 Corporate Update Call. I’m Andrew with Chorus Call and will facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, PhD, Chief Scientific Officer; Kelly McKee, M.D., M.P.H, Chief Medical Officer; and John Sharkey, PhD, Vice President, Business Development. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions.